International Biotechnology Trust’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $4.07M | Hold |
58,300
| – | – | 1.37% | 22 |
|
|
2023
Q2 | $4.19M | Buy |
+58,300
| New | +$4.19M | 1.27% | 25 |
|
|
2022
Q4 | – | Sell |
-14,000
| Closed | -$625K | – | 64 |
|
|
2022
Q3 | $625K | Buy |
14,000
+13,465
| +2,517% | +$601K | 0.2% | 57 |
|
|
2022
Q2 | $14K | Sell |
535
-13,465
| -96% | -$352K | 0.15% | 72 |
|
|
2022
Q1 | $5.4M | Buy |
+14,000
| New | +$5.4M | 1.22% | 28 |
|
|
2021
Q4 | – | Sell |
-14,000
| Closed | -$461K | – | 75 |
|
|
2021
Q3 | $461K | Hold |
14,000
| – | – | 0.11% | 60 |
|
|
2021
Q2 | $944K | Hold |
14,000
| – | – | 0.25% | 52 |
|
|
2021
Q1 | $793K | Hold |
14,000
| – | – | 0.21% | 51 |
|
|
2020
Q4 | $1.14M | Buy |
+14,000
| New | +$1.14M | 0.31% | 40 |
|